Celgene

NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing price July 1, 2020
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Thursday was a down day for the broad U.S. markets. After a fairly decent Wednesday, markets as a whole took a sharp turn downward. Perhaps a driving force from this was Apple lowering its...
Bristol-Myers has announced a definitive agreement to acquire rival Celgene in a cash and stock deal worth $74 billion. Celgene shareholders are scheduled to receive a 54% premium to Wednesday...
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The top analyst upgrades, downgrades and other research calls from Friday included Apple, Applied Materials, Biogen, CyberArk, Electronic Arts, Marathon, Nike and NXP Semiconductors.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in...
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.